Human papillomavirus vaccination coverage, policies, and practical implementation across Europe.

[1]  Anne M Johnson,et al.  Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis , 2019, The Lancet.

[2]  L. Ward,et al.  Interventions to increase uptake of the human papillomavirus vaccine in unvaccinated college students: A systematic literature review , 2019, Preventive medicine reports.

[3]  J. Hadler,et al.  Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Mølbak,et al.  Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination , 2018, BMC Public Health.

[5]  P. Peretti-Watel,et al.  Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study. , 2018, Vaccine.

[6]  H. Marshall,et al.  The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  P. van Damme,et al.  HPV immunization programs: Ensuring their sustainability and resilience. , 2018, Vaccine.

[8]  B. Corcoran,et al.  Rapid response to HPV vaccination crisis in Ireland , 2018, The Lancet.

[9]  N. Low,et al.  Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey , 2017, International Journal of Public Health.

[10]  V. Gianfredi,et al.  Immunisation Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  J. Ebbert,et al.  Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. , 2016, Preventive medicine.

[12]  M. Theodoridou,et al.  Vaccination against Human Papillomavirus in relation to Financial Crisis: The "Evaluation and Education of Greek Female Adolescents on Human Papillomaviruses' Prevention Strategies" ELEFTHERIA Study. , 2016, Journal of pediatric and adolescent gynecology.

[13]  G. Colditz,et al.  Interventions to Improve HPV Vaccine Uptake: A Systematic Review , 2016, Pediatrics.

[14]  N. Muñoz,et al.  Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Sparén,et al.  Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study , 2016, International journal of cancer.

[16]  L. Niccolai,et al.  Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review. , 2015, JAMA pediatrics.

[17]  Kate Soldan,et al.  Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis , 2015, BDJ.

[18]  J. Dillner,et al.  Organization and quality of HPV vaccination programs in Europe. , 2015, Vaccine.

[19]  O. Wichmann,et al.  Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany. , 2014, Vaccine.

[20]  M. Poljak,et al.  Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe. , 2013, Vaccine.

[21]  J. Brotherton,et al.  Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach , 2013, The Medical journal of Australia.

[22]  J. Seidel,et al.  Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada , 2013, BMC Public Health.

[23]  A. Localio,et al.  Effectiveness of Decision Support for Families, Clinicians, or Both on HPV Vaccine Receipt , 2013, Pediatrics.

[24]  A. Băban,et al.  "Who will take the blame?": understanding the reasons why Romanian mothers decline HPV vaccination for their daughters. , 2012, Vaccine.

[25]  E. Lynge,et al.  Introduction of human papillomavirus vaccination in Nordic countries. , 2012, Vaccine.

[26]  P. Vanhems,et al.  Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. , 2011, Vaccine.

[27]  P. Lopalco,et al.  The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  S. Salmaso,et al.  Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  Jane Wardle,et al.  Parental attitudes to pre-pubertal HPV vaccination. , 2007, Vaccine.